YM BIOSCIENCES REPORTS FIRST QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS MISSISSAUGA, ON, Nov. 11 /CNW/ - YM BioSciences Inc. (NYSE Alternext...
YM BIOSCIENCES REPORTS DATA FROM EXPLORATORY CLINICAL TRIALS OF NIMOTUZUMAB IN BRAIN METASTASES AND HIGH-GRADE GLIOMA PRESENTED AT 2008...
YM BIOSCIENCES REPORTS DAIICHI AND KUHNIL ENROL FIRST PATIENTS IN RANDOMIZED PHASE II GASTRIC TRIAL - International Clinical Study Follows...
YM BIOSCIENCES REPORTS FISCAL YEAR END 2008 OPERATIONAL AND FINANCIAL RESULTS MISSISSAUGA, ON, Sept. 19 /CNW/ - YM BioSciences Inc. (AMEX: YMI...
YM BIOSCIENCES ANNOUNCES STAFFING CHANGES MISSISSAUGA, ON, Aug. 5 /CNW/ - YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology...
NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER MISSISSAUGA, ON, Aug. 5...
YM BIOSCIENCES REPORTS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER - Overall Survival And Disease Control Outcomes, Coupled...
YM BIOSCIENCES PRESENTS DATA COMPARING MECHANISM OF ACTION FOR EGFR ANTIBODY, NIMOTUZUMAB TO CETUXIMAB AND PANITUMUMAB, AT THE AACR CENTENNIAL...
Attention Business Editors: YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL - Dr...
NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING MISSISSAUGA, ON, June 2 /CNW/ - YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM:...
YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING MISSISSAUGA, June 2 /CNW/ - YM BioSciences Inc. (AMEX: YMI, TSX:...
YM BIOSCIENCES REPORTS FISCAL THIRD QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS MISSISSAUGA, ON, May 8 /CNW/ - YM BioSciences Inc. (AMEX: YMI...
YM BIOSCIENCES ANNOUNCES SCHEDULE OF NIMOTUZUMAB PRESENTATIONS AT ASCO 2008 ANNUAL MEETING MISSISSAUGA, ON, May 5 /CNW/ - YM BioSciences Inc...
YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING MISSISSAUGA, ON, May 5 /CNW/ - YM BioSciences Inc...
YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING MISSISSAUGA, ON, April 11 /CNW/ - YM BioSciences...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.